MOACM
AGIO icon

Mutual of America Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Mutual of America Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-750
Closed -$27K – 1680
2020
Q1 		$27K Hold
750
– – ﹤0.01% 1421
2019
Q4 		$36K Hold
750
– – ﹤0.01% 1431
2019
Q3 		$24K Hold
750
– – ﹤0.01% 1532
2019
Q2 		$37K Sell
750
-24,482
-97% -$1.31M ﹤0.01% 1410
2019
Q1 		$1.7M Buy
25,232
+839
+3% +$48.9K 0.02% 949
2018
Q4 		$1.13M Hold
24,393
– – 0.02% 1021
2018
Q3 		$1.88M Sell
24,393
-164
-0.7% -$13.2K 0.03% 923
2018
Q2 		$2.07M Sell
24,557
-2,648
-10% -$231K 0.03% 871
2018
Q1 		$2.23M Sell
27,205
-3,362
-11% -$260K 0.03% 802
2017
Q4 		$1.75M Buy
30,567
+211
+0.7% +$13.3K 0.03% 918
2017
Q3 		$2.03M Buy
30,356
+6,100
+25% +$366K 0.03% 831
2017
Q2 		$1.25M Sell
24,256
-842
-3% -$43K 0.02% 1012
2017
Q1 		$1.47M Buy
25,098
+8,004
+47% +$384K 0.03% 952
2016
Q4 		$713K Sell
17,094
-86
-0.5% -$4.51K 0.01% 1078
2016
Q3 		$907K Hold
17,180
– – 0.02% 1031
2016
Q2 		$720K Hold
17,180
– – 0.02% 1077
2016
Q1 		$698K Sell
17,180
-145
-0.8% -$6.2K 0.02% 1073
2015
Q4 		$1.13M Buy
17,325
+86
+0.5% +$5.64K 0.03% 937
2015
Q3 		$1.22M Buy
17,239
+60
+0.3% +$5.86K 0.03% 894
2015
Q2 		$1.91M Buy
17,179
+6,000
+54% +$646K 0.04% 734
2015
Q1 		$1.05M Buy
+11,179
New +$1.25M 0.02% 992

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Mutual of America Capital Management's AGIO Position: Q2 2020 in Review

Mutual of America Capital Management sold out of Agios Pharmaceuticals (AGIO) in Q2 2020, closing a stake of 750 shares — an estimated $27K sold.

Mutual of America Capital Management first reported a position in AGIO in Q1 2015 and held it in 21 quarters. The position peaked at $2.23M in Q1 2018. 217 funds tracked by Wall St. Rank hold AGIO as of Q2 2020.

  • Mutual of America Capital Management reported no remaining Agios Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Mutual of America Capital Management sold 750 Agios Pharmaceuticals shares in Q2 2020, an estimated $27K.
  • Mutual of America Capital Management first reported a position in Agios Pharmaceuticals in Q1 2015 and held it in 21 quarters.
  • Mutual of America Capital Management's Agios Pharmaceuticals position peaked at $2.23M in Q1 2018.
  • 217 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2020.

Based on Mutual of America Capital Management's 13F filing for Q2 2020, filed 6 Aug 2020.